@American_Heart’s official account for meetings, science news, funding opportunities and membership. RTs/Follows not endorsements. Pump up your career, here.
Dallas, TX
Joined January 2009
- Tweets13.7K
- Following4.7K
- Followers75.9K
- Likes4.6K
Pinned Tweet
For the first time, @American_Heart, @AmerAcadPeds, @acog, and the Society for Maternal-Fetal Medicine have come together to release shared guidance to help clinicians identify cardiovascular risk early and take action.
The landmark three-part publication series highlights how female-specific biology affects girls’ and women’s hearts and creates a “Female Life Stage” framework to help protect heart health from puberty through menopause and beyond.
The Female Life Stage framework is based on female biology and offers windows of opportunity to prevent heart disease and stroke and manage future disease risk.
Each life stage is defined by a change in hormones that is uniquely experienced by girls and women, with pregnancy identified as an event affecting cardiovascular health that may occur at any or multiple life stages:
➡️ Stage 1 perimenarche - This stage represents the transition after the first menstrual period. Approximate age range is 8 – 15 years.
➡️ Stage 2 ovarian cycling - Regular ovulatory and hormone cycles are established and when pregnancy may occur. Approximate age range is 15 – 44 years.
➡️ Stage 3 perimenopause - This stage represents the transition to variable cycle length, skipped cycles and hormone changes. Approximate age range is 45-51 years.
➡️ Stage 4 postmenopause – This stage represents the years that begin after menopause or 12 months after the final menstrual period. Approximate age is 51 years and older.
➡️ Pregnancy, in any life stage – the time before, during and after pregnancy is highlighted as a biological “stress test” that can identify cardiovascular risks that may have been previously unrecognized.
✍🏼 @heartDocSadiya
📷 The Female Life Stage framework for the prevention and management of cardiovascular disease in girls and women
professional.heart.org/en/sc…
Join Researchers at Heart at #ScientificSessions26 at these great events. Details below ⬇️
🔹 Research Alumni Reception
📅 5- 6 p.m. Nov. 7
🔹 Inside the Heart Association's Research Enterprise: Grant Funding and Other Opportunities
📅 3:30-4:30 p.m. Nov. 8
Share and bookmark this post for Scientific Sessions in Chicago!
ALT Promotional poster for "Scientific Sessions 2026" featuring a heart logo. Text invites attendees to "Join Researchers at Heart at #ScientificSessions26" and includes event dates, November 6-9, 2026, in Chicago, IL. Red and white background design.
ALT The image is an event poster for "#ScientificSessions26" by the Heart Association. It details a session about research grants on Nov. 8, from 3:30-4:30 PM CT at Learning Studio 5, Science & Technology Hall. Points include insights into research funding, peer review, career stage programs, application timelines, and career development. Presented by Gordon Tomaselli, MD, FAHA. The poster features the Heart Association and Scientific Sessions logos.
ALT Flyer for #ScientificSessions26 Research Alumni Reception. Features event details such as networking opportunities, hors d'oeuvres, and a group photo session. Scheduled for Nov. 7, 5-6 PM CT, at North Building, Level 3, Center Stage Entrance. Logos of Scientific Sessions are present.
A paradigm shift in women’s cardiovascular (CV) care is required.
This Female Life Stage framework provides a unifying, person centered approach across the life course beginning with menarche and through the years after menopause to optimize CV health for all girls, women, and their communities.
Physiologic changes in sex hormones define clinically distinct life stages: perimenarche, ovarian cycling, perimenopause, postmenopause, each informing female-specific screening, prevention, and management. The peripregnancy period and exposure to exogenous hormone therapy can be considered as cross-cutting modifiers. Premenarche does not have sex-specific guidance for CV health, but is a foundational period to long-term CV health with CV health behaviors and attitudes being developed early.
@American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal Medicine jointly approve this shared model.
📷 Interconnected hormonal, psychosocial, and cardiovascular health across the female life course.
✍🏼 @heartDocSadiya
professional.heart.org/en/sc…
Improving cardiovascular health in women is an urgent public health priority.
Persistent gaps remain in awareness, prevention, and management of cardiovascular disease (CVD) in women. Only 41% of women identify heart disease as the leading cause of death. CVD accounts for >400,000 deaths among US women in 2024, which is more than breast cancer, lung cancer, and chronic lung disease combined.
The Advisory describes the current landscape and proposes a novel infrastructure to support expansion of dedicated Comprehensive Centers of Excellence (CCoE) for Women's Cardiovascular Care: interdisciplinary care models built on four interdisciplinary pillars: clinical care, education and training, research, and community partnerships. Integrated pathways spanning disciplines can reduce fragmentation, enable earlier risk identification, and expand women's representation in clinical research.
@American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal Medicine jointly approve this shared model.
📷 Examples of women’s cardiovascular health education topics across medical education and training.
✍🏼 @heartDocSadiya
professional.heart.org/en/sc…
AHA Science retweeted
@avolgman, @DrLaxmiMehta, and @Gina_Lundberg discuss the importance of a life-course approach to improving women's cardiovascular health in a new commentary accompanying the AHA Presidential Advisory. ahajournals.org/doi/10.1161/…
A paradigm shift in women’s cardiovascular (CV) care is required.
This Female Life Stage framework provides a unifying, person centered approach across the life course beginning with menarche and through the years after menopause to optimize CV health for all girls, women, and their communities.
Physiologic changes in sex hormones define clinically distinct life stages: perimenarche, ovarian cycling, perimenopause, postmenopause, each informing female-specific screening, prevention, and management. The peripregnancy period and exposure to exogenous hormone therapy can be considered as cross-cutting modifiers. Premenarche does not have sex-specific guidance for CV health, but is a foundational period to long-term CV health with CV health behaviors and attitudes being developed early.
@American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal Medicine jointly approve this shared model.
📷 Interconnected hormonal, psychosocial, and cardiovascular health across the female life course.
✍🏼 @heartDocSadiya
professional.heart.org/en/sc…
AHA Science retweeted
"Recognition without action will not improve cardiovascular outcomes, but action must be guided by evidence. The next phase of women's cardiovascular health requires both." Commentary from Michael Honigberg and colleagues on the path forward.
ahajrnls.org/4BnFdfP
AHA Science retweeted
What will it take to deliver high-quality, high-impact cardiovascular care for women? @TYWangMD explores this question in a new commentary.
ahajrnls.org/4BrRksa
AHA Science retweeted
From menarche to menopause and beyond, women's cardiovascular health shouldn't fall through the gaps. In a new commentary, Karen Florio and colleagues call for better coordination between gynecology and cardiology across the life course. ahajournals.org/doi/10.1161/…
Improving cardiovascular health in women is an urgent public health priority.
Persistent gaps remain in awareness, prevention, and management of cardiovascular disease (CVD) in women. Only 41% of women identify heart disease as the leading cause of death. CVD accounts for >400,000 deaths among US women in 2024, which is more than breast cancer, lung cancer, and chronic lung disease combined.
The Advisory describes the current landscape and proposes a novel infrastructure to support expansion of dedicated Comprehensive Centers of Excellence (CCoE) for Women's Cardiovascular Care: interdisciplinary care models built on four interdisciplinary pillars: clinical care, education and training, research, and community partnerships. Integrated pathways spanning disciplines can reduce fragmentation, enable earlier risk identification, and expand women's representation in clinical research.
@American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal Medicine jointly approve this shared model.
📷 Examples of women’s cardiovascular health education topics across medical education and training.
✍🏼 @heartDocSadiya
professional.heart.org/en/sc…
AHA Science retweeted
Women's cardiovascular health begins in childhood. In a commentary accompanying the new Compendium, Jessica Shim and colleagues explore how menstrual and gynecologic history can offer early clues to future cardiovascular risk and inform earlier prevention.
ahajrnls.org/4i8qhuw
This joint Scientific Statement on behalf of @American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal presents stage-specific clinical guidance across the interconnected domains of hormonal health, psychosocial health, and cardiovascular (CV) health across the female life course.
The three anchoring principles of this statement are:
(1) Endogenous sex hormones are dynamic and produce physiologic changes accessible without labs.
(2) Hormonal transitions (perimenarche, perimenopause, peripregnancy) are windows of opportunity that reflect changing vulnerability to psychosocial stressors and CVD risk.
(3) The framework makes explicit the interconnectedness of hormonal, psychosocial, and CV health.
@American_Heart, @AmerAcadPeds, @acog and the Society for Maternal-Fetal Medicine jointly approve this shared model.
📷 Female Life Stage chart assessing interconnected domains of hormonal, psychosocial, and cardiovascular health
✍🏼 @heartDocSadiya
professional.heart.org/en/sc…
Fuel your discoveries with funding, mentorship and the powerful research network of the American Heart Association. Don’t miss a chance to advance science and save lives. Applications are open.
Explore research grant opportunities at bit.ly/4s52fnf.
ALT A poster with the logo of the American Heart Association, featuring the text: "Advancing Science. Advancing You. Learn about upcoming funding deadlines.
AHA Science retweeted
📣Calling all #AHFTC Fellows!📣
@CircHF is proud to launch the 2nd year of the journal's free educational webinar series for current & past AHFTC fellows
📌9 live virtual sessions
📌New topic each session
📅Start Date: November 18, 2026
🔗Learn More: ahajournals.org/circheartfai…
📣 We’re looking to support innovative, high-impact research that could lead to critical discoveries or major advancements in cardiovascular and/or cerebrovascular research. Apply today. 👇
Find more information on this opportunity here: bit.ly/4zxdl76
ALT A graphic featuring the American Heart Association logo, with "2027 Innovative Project Award" in bold text. Below, it reads "Submit your proposal by December 9.
Ready to jumpstart your research career? If you’re in the early years of your first professional appointment, this grant will support your research, training and mentorship to ensure your future success as a research scientist. Apply today. 👇
Find more information on this opportunity here: bit.ly/4jr4DTi
ALT The image contains the American Heart Association logo, a red heart with a torch. Text reads: "Career Development Award. Submit your proposal by December 1.
New programming formats, expanded learning opportunities and innovative experiences make #ScientificSessions26 a must-attend event. Join us in Chicago for 4-days of science.
2026 Chairs: @JoChikweMD, @bnallamo
Register now: bit.ly/458Naqj
ALT Graphic for Scientific Sessions 2026 featuring a heart logo. The text highlights "The Future of Cardiovascular and Brain Health," happening November 6-9 in Chicago, IL. Includes the tagline: "Four Days. Global Experts. Limitless Discovery." The Scientific Sessions logo is at the bottom.
Congratulations to Lawrence J. Appel, M.D., M.P.H., FAHA, recipient of the 2026 Research Achievement Award! 🏆
From the landmark DASH trials to decades of research in hypertension, nutrition and cardiovascular prevention, Dr. Appel’s work has transformed our understanding of heart health and helped shape care around the world. His scientific contributions continue to improve the prevention and treatment of cardiovascular disease for millions.
Learn more: bit.ly/47GWp22
ALT This image is a promotional poster for the "2026 Research Achievement Award." It mentions Lawrence J. Appel as a recipient for contributions to diet, nutrition, and hypertension. The event is scheduled for November 6-9 in Chicago, IL. The poster features the American Heart Association logo and the "Scientific Sessions" logo.
Congratulations to @emilyswlau, M.D., M.P.H., FAHA, recipient of the 2026 Dr. Nanette K. Wenger Research Goes Red® Award for Best Scientific Article on Cardiovascular Disease and Stroke in Women. 🏆
Through groundbreaking research on cardiovascular health and pregnancy, Dr. Lau is helping advance our understanding of heart disease in women and inform better prevention and care for future generations. Join us in celebrating this well-deserved recognition. 👏
Learn More: bit.ly/4rK3CHS
